PRDX4 and polycystic ovary syndrome: In human cell lines, PRDX4 was identified either as a cytoplasmic protein attenuating NF-kappa B activation [26], or as a secretable protein activating both NF-kappa B and JNK [38], both of which were involved in apoptosis of GCs and the pathologic progress of PCOS [39], [40].